MENU
+Compare
NRXP
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$2.09
Change
+$0.11 (+5.56%)
Capitalization
32.31M

NRXP NRX Pharmaceuticals Forecast, Technical & Fundamental Analysis

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases... Show more

NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NRXP with price predictions
Apr 23, 2025

NRXP's RSI Oscillator climbs out of oversold territory

The RSI Oscillator for NRXP moved out of oversold territory on April 09, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 39 similar instances when the indicator left oversold territory. In of the 39 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on NRXP as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NRXP just turned positive on April 11, 2025. Looking at past instances where NRXP's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NRXP advanced for three days, in of 208 cases, the price rose further within the following month. The odds of a continued upward trend are .

NRXP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 41 cases where NRXP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NRXP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NRXP entered a downward trend on April 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NRXP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.056). P/E Ratio (0.358) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.992).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NRXP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NRXP is expected to report earnings to fall 93.24% to -5 cents per share on May 14

NRX Pharmaceuticals NRXP Stock Earnings Reports
Q1'24
Est.
$-0.05
Q4'24
Missed
by $0.66
Q4'23
Missed
by $0.43
Q3'23
Beat
by $0.04
Q2'23
Beat
by $0.01
The last earnings report on March 14 showed earnings per share of -74 cents, missing the estimate of -7 cents. With 52.09K shares outstanding, the current market capitalization sits at 32.31M.
A.I. Advisor
published General Information

General Information

is a blank check company, which engages in a stock exchange, asset acquisition, stock purchase, and reorganization

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1201 Orange Street
Phone
+1 484 254-6134
Employees
N/A
Web
https://nrxpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRNS0.820.06
+8.02%
Barinthus Biotherapeutics plc
KRG21.840.25
+1.16%
Kite Realty Group Trust
FIS79.410.29
+0.37%
Fidelity National Information Services
FNLC24.21-0.19
-0.78%
First Bancorp
ALEX16.64-0.18
-1.07%
Alexander & Baldwin

NRXP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with RNAC. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
+3.66%
RNAC - NRXP
86%
Closely correlated
+3.37%
NCNA - NRXP
85%
Closely correlated
+14.09%
SNPX - NRXP
84%
Closely correlated
+8.28%
AGEN - NRXP
83%
Closely correlated
-0.70%
ALLR - NRXP
81%
Closely correlated
+1.93%
More

Groups containing NRXP

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
+3.66%
NRXP
(7 stocks)
17%
Poorly correlated
-1.11%